Injective (INJ) registered a 13.68% recovery in the last 24 hours as buyers bounced back after defending a key support area near $4.19.
Recoil is gone injective Despite the slight decrease in trading volume, its market capitalization increased by around $4.89 to $489.67 million.
Trading activity fell 1.16% to $145.85 million during the same period. However, the recovery has encouraged traders to re-evaluate the recent downtrend after INJ made a strong rebound from its recent lows.
Why are top traders still betting against INJ?
The price made a strong recovery, but leading traders on Binance remained bearish throughout the rise. Long accounts represented only 41.09%, while 58.91% of accounts remained short. Long/Short Ratio 0.70.
The imbalance showed that many experienced traders expected the recovery to fade despite double-digit gains.
Despite this, the ongoing short position also increased the possibility of additional buying pressure if the price continued to rise. A sustained move beyond nearby resistance could force bearish traders to close their positions, fueling progress.
But until that happens, the market remains cautious in lieu of broad bullish belief among leveraged participants.
Buyers are back but sellers still control order flow
Derivatives data showed a mixed picture despite the strong recovery.
Futures Volume Bubble Map It has entered an overheating phase, indicating that trading activity is rapidly accelerating as the price rebounds from support.
Increased participation often reflects stronger interest from both buyers and sellers rather than directional certainty. However, Futures Buyer CVD maintained seller dominance, indicating that sell orders in the market continue to outweigh aggressive buying activity during the recent recovery.
Currently, the rally is largely dependent on continued Spot demand to overcome persistent selling pressure before another bullish wave develops.
Can buyers break back the $5 barrier?
ENJ After defending the $4.19 support level, it rebounded sharply and climbed towards the psychological $5.00 resistance.
The daily chart showed that buyers regained control after several sessions of decline, but the price is still trading below previous highs near $5.68 and $7.00.
Meanwhile, the Relative Strength Index recovered to 46.67 after recently approaching the oversold zone, indicating that bearish pressure has eased significantly before entering bullish territory.
The RSI moving average remained around 44.92, reinforcing the developing structure as buying interest returned. If the buyers continue the current rally and reclaim $5, the next upside target could emerge near $5.68.
Failure to secure this level could encourage a retest of $4.19 before a stronger recovery develops.
Will Injective reach $7 next?
INJ has rallied convincingly from a key support zone, but some signals still reflect cautious sentiment in the market.
Leading traders continued to favor short positions, while buyer activity remained seller-dominated despite the recovery.
If buyers regain $5 with sustained demand, the price could rise as high as $5.68 before challenging $7.00.
Final Summary
- INJ rebounded strongly from key support but bearish trader positioning continued to limit confidence.
- A break above $5 could strengthen the recovery, while a rejection could revive selling pressure.
